|
Catalogue
Number
|
Product
|
Order number / Unit
|
|
|
2750
|
Cyclopropyl-p-nitrophenyl ketone
|
2750.0002: 2 mg per vial
Please inquire for customized
filling and bulk quantities.
|
|
|
Precursor for [18F]-labelled building block for different alkylbenzenes
(fluorine-18-labelled haloperidol, spiperone, N-(p-nitrobenzyl)spiperone, N-methyl-spiroperidol, BMY14802, 3-N-methyl-benperidol, benperidol)
|
|
|
|
|
|
|
|
|
Molar Mass: 191.18
|
|
|
C10H9NO3
|
|
|
[93639-12-4]
|
|
|
|
|
|
Pale yellow needles packaged in dark glass crimp cap vials.
|
|
|
|
|
|
|
|
|
Purity: > 99 %
|
|
|
Certificates:
CoA; 1H NMR spectrum, HPLC
|
|
|
Chemical Name:
CA index name: Methanone, cyclopropyl-(4-nitrophenyl)-
|
|
|
Synonymes:
Cyclopropyl-p-nitrophenyl ketone
|
|
|
Literature:
1. Hashizume K. et al. Rapid and efficient synthesis of high-purity fluorine-18 labeled haloperidol and spiperone via the nitro precursor in combination with a new HPLC separation method. Bull. Chem. Soc. Jpn. 1997, 70, 681-687.
|
|
|
2. Mach R. H. et al. Synthesis and in vivo evaluation of [18F]-N-(p-nitrobenzyl)spiperone ([18F]PNBS) in rats. Nucl. Med. Biol. 1993, 20, 269-278.
|
|
|
3. Moerlein S. M. et al. Production of fluorine-18-labeled (3-N-methyl)benperidol for PET investigation of cerebral dopaminergic receptor binding. Int. J. Rad. Appl. Instrum. A 1992, 43, 913-917.
|
|
|
4. Shiue C. Y. et al. Synthesis of (±)-[18F]BMY14802, its enantiomers and their anatomical distribution in mice. Nucl. Med. Biol. 1993, 20, 625-630.
|
|
|
|
|
|
date of product catalogue issue:
05 April 2012
|